Abundant macrophages and high SRC‐1 expression in CD68+ cells were observed in patients with pancreatic cancer in the “with PNI group,” whereas the expression of SRC‐1 in CD68+ cells was comparatively low in the “without PNI group” (Figure2A). Here, CD68 is linked to pancreatic neoplasm.